0
     

Report Added
Report already added
Global Bleeding Disorders Treatment Market By Drug Type (Plasma-derived Coagulation Factor Concentrates, Recombinant Coagulation Factor Concentrates, Desmopressin, Antifibrinolytics, Fibrin Sealants, Others), By Disease Type (Hemophilia A, Hemophilia B, Von Willebrand Disease, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online), By End User (Clinics, Hospitals, Research Institutes, Others) By Region, Competition, Forecast & Opportunities, 2027

Global Bleeding Disorders Treatment Market By Drug Type (Plasma-derived Coagulation Factor Concentrates, Recombinant Coagulation Factor Concentrates, Desmopressin, Antifibrinolytics, Fibrin Sealants, Others), By Disease Type (Hemophilia A, Hemophilia B, Von Willebrand Disease, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online), By End User (Clinics, Hospitals, Research Institutes, Others) By Region, Competition, Forecast & Opportunities, 2027

The global bleeding disorders treatment market is projected to witness a steady CAGR during the forecast period, 2023-2027. Factors such as the rise in the patient population base, increased healthcare expenditure by the public and private players, and growing disposable income for middle-class families drive the global bleeding disorders treatment market. The ongoing research and development activities and the increased focus of pharmaceutical companies on recombinant products are expected to create lucrative growth opportunities for the global bleeding disorders treatment market in the next five years. However, limited reimbursement and the high cost of availing of bleeding disorder treatment facilities may hinder the market growth in the forecast period.
The global bleeding disorders treatment market is segmented into drug type, disease type, distribution channel, end user, regional distribution, and competitive landscape. Based on drug type, the market is fragmented into plasma-derived coagulation factor concentrates, recombinant coagulation factor concentrates, desmopressin, antifibrinolytics, fibrin sealants, and others. The recombinant coagulation factor concentrates segment is expected to capture the highest market share during the forecast period, 2023-2027. Their high efficiency in preventing bleeding than plasma-derived coagulation factor concentrates is expected to drive the market demand in the next five years.
North America is expected to dominate the global bleeding disorders treatment market in the forecast period. The compatibility of the population of all age groups in the United States for prophylaxis treatment is driving the market demand in the region.
The major players operating in the global bleeding disorders treatment market are Bayer AG, Pfizer Inc., Grifols S.A., Octapharma AG, Sun Pharmaceuticals Industries Ltd., Ferring Pharmaceuticals SA, Amgen Inc., Sanofi SA, Baxter International Inc., F. Hoffmann-La Roche Ltd., Takeda Pharmaceuticals Ltd., Novo Nordisk A/S, Novartis AG, Eli Lilly and Company Ltd., Gilead Sciences Inc., among others. The companies are focusing on extensive research and development activities to stay competitive in the market.

Years considered for this report:
Historical Years: 2017 – 2020
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2023 – 2027

Objective of the Study:

•To analyze and forecast the market size of global bleeding disorders treatment market from 2017 to 2021.
•To estimate and forecast the market size of global bleeding disorders treatment market from 2022 to 2027 and growth rate until 2027.
•To classify and forecast global bleeding disorders treatment market based on drug type, disease type, distribution channel, end user, and regional distribution.
•To identify dominant region or segment in the global bleeding disorders treatment market.
•To identify drivers and challenges for global bleeding disorders treatment market.
•To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in Global bleeding disorders treatment market.
•To identify and analyze the profile of leading players operating in Global bleeding disorders treatment market.
•To identify key sustainable strategies adopted by market players in Global bleeding disorders treatment market.
TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers, suppliers, and service providers across the country. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufactures which could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufactures, distribution channels and presence of all major players across the country.
TechSci Research calculated the market size of Global bleeding disorders treatment market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:
•Bleeding disorders treatment vendors, end users, service providers and other stakeholders
•Distributers and suppliers of bleeding disorders treatment’s products and services and other stakeholders
•Organizations, forums, and alliances related to bleeding disorders treatment
•Market research and consulting firms
The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:
In this report, Global bleeding disorders treatment market has been segmented into following categories, in addition to the industry trends which have also been detailed below:
•Market, By Drug Type:
oPlasma-derived Coagulation Factor Concentrates
oRecombinant Coagulation Factor Concentrates
oDesmopressin
oAntifibrinolytics
oFibrin Sealants
oOthers
•Market, By Disease Type:
oHemophilia A
oHemophilia B
oVon Willebrand Disease
oOthers
•Market, By Distribution Channel:
oHospital Pharmacies
oRetail Pharmacies
oOnline
•Market, By End User:
oClinics
oHospitals
oResearch Institutes
oOthers
•Market, By Region:
oNorth America
oAPAC
oEurope
oMEA
oSouth America
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in Global bleeding disorders treatment market.

Available Customizations:
With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information
•Detailed analysis and profiling of additional market players (up to five).
Table of Content

1.Product Overview
2.Research Methodology
3.Impact of COVID-19 on Global Bleeding Disorders Treatment Market
4.Executive Summary
5.Voice of Customer
6.Global Bleeding Disorders Treatment Market Outlook
6.1.Market Size & Forecast
6.1.1.By Value
6.2.Market Share & Forecast
6.2.1.By Drug Type (Plasma-derived Coagulation Factor Concentrates, Recombinant Coagulation Factor Concentrates, Desmopressin, Antifibrinolytics, Fibrin Sealants, Others)
6.2.2.By Disease Type (Hemophilia A, Hemophilia B, Von Willebrand Disease, Others)
6.2.3.By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online)
6.2.4.By End User (Clinics, Hospitals, Research Institutes, Others)
6.2.5.By Company (2021)
6.2.6.By Region (North America, Europe, Asia-Pacific, South America, Middle East & Africa)
6.3.Product Market Map
7.North America Bleeding Disorders Treatment Market Outlook
7.1.Market Size & Forecast
7.1.1.By Value
7.2.Market Share & Forecast
7.2.1.By Drug Type
7.2.2.By Disease Type
7.2.3.By Distribution Channel
7.2.4.By End User
7.2.5.By Country (United States; Canada; Mexico)
7.3.North America: Country Analysis
7.3.1.United States Bleeding Disorders Treatment Market Outlook
7.3.1.1.Market Size & Forecast
7.3.1.1.1.By Value
7.3.1.2.Market Share & Forecast
7.3.1.2.1.By Drug Type
7.3.1.2.2.By Disease Type
7.3.1.2.3.By Distribution Channel
7.3.1.2.4.By End User
7.3.2.Canada Bleeding Disorders Treatment Market Outlook
7.3.2.1.Market Size & Forecast
7.3.2.1.1.By Value
7.3.2.2.Market Share & Forecast
7.3.2.2.1.By Drug Type
7.3.2.2.2.By Disease Type
7.3.2.2.3.By Distribution Channel
7.3.2.2.4.By End User
7.3.3.Mexico Bleeding Disorders Treatment Market Outlook
7.3.3.1.Market Size & Forecast
7.3.3.1.1.By Value
7.3.3.2.Market Share & Forecast
7.3.3.2.1.By Drug Type
7.3.3.2.2.By Disease Type
7.3.3.2.3.By Distribution Channel
7.3.3.2.4.By End User
8.Europe Bleeding Disorders Treatment Market Outlook
8.1.Market Size & Forecast
8.1.1.By Value
8.2.Market Share & Forecast
8.2.1.By Drug Type
8.2.2.By Disease Type
8.2.3.By Distribution Channel
8.2.4.By End User
8.2.5.By Country (France; Germany; UK; Italy; Spain)
8.3.Europe: Country Analysis
8.3.1.France Bleeding Disorders Treatment Market Outlook
8.3.1.1.Market Size & Forecast
8.3.1.1.1.By Value
8.3.1.2.Market Share & Forecast
8.3.1.2.1.By Drug Type
8.3.1.2.2.By Disease Type
8.3.1.2.3.By Distribution Channel
8.3.1.2.4.By End User
8.3.2.Germany Bleeding Disorders Treatment Market Outlook
8.3.2.1.Market Size & Forecast
8.3.2.1.1.By Value
8.3.2.2.Market Share & Forecast
8.3.2.2.1.By Drug Type
8.3.2.2.2.By Disease Type
8.3.2.2.3.By Distribution Channel
8.3.2.2.4.By End User
8.3.3.United Kingdom Bleeding Disorders Treatment Market Outlook
8.3.3.1.Market Size & Forecast
8.3.3.1.1.By Value
8.3.3.2.Market Share & Forecast
8.3.3.2.1.By Drug Type
8.3.3.2.2.By Disease Type
8.3.3.2.3.By Distribution Channel
8.3.3.2.4.By End User
8.3.4.Italy Bleeding Disorders Treatment Market Outlook
8.3.4.1.Market Size & Forecast
8.3.4.1.1.By Value
8.3.4.2.Market Share & Forecast
8.3.4.2.1.By Drug Type
8.3.4.2.2.By Disease Type
8.3.4.2.3.By Distribution Channel
8.3.4.2.4.By End User
8.3.5.Spain Bleeding Disorders Treatment Market Outlook
8.3.5.1.Market Size & Forecast
8.3.5.1.1.By Value
8.3.5.2.Market Share & Forecast
8.3.5.2.1.By Drug Type
8.3.5.2.2.By Disease Type
8.3.5.2.3.By Distribution Channel
8.3.5.2.4.By End User
9.Asia-Pacific Bleeding Disorders Treatment Market Outlook
9.1.Market Size & Forecast
9.1.1.By Value
9.2.Market Share & Forecast
9.2.1.By Drug Type
9.2.2.By Disease Type
9.2.3.By Distribution Channel
9.2.4.By End User
9.2.5.By Country (China; India; Japan; South Korea; Australia)
8.3Asia-Pacific: Country Analysis
8.3.1China Bleeding Disorders Treatment Market Outlook
8.3.1.1Market Size & Forecast
8.3.1.1.1By Value
8.3.1.2Market Share & Forecast
8.3.1.2.1By Drug Type
8.3.1.2.2By Disease Type
8.3.1.2.3By Distribution Channel
8.3.1.2.4By End User
8.3.2India Bleeding Disorders Treatment Market Outlook
8.3.2.1Market Size & Forecast
8.3.2.1.1By Value
8.3.2.2Market Share & Forecast
8.3.2.2.1By Drug Type
8.3.2.2.2By Disease Type
8.3.2.2.3By Distribution Channel
8.3.2.2.4By End User
8.3.3Japan Bleeding Disorders Treatment Market Outlook
8.3.3.1Market Size & Forecast
8.3.3.1.1By Value
8.3.3.2Market Share & Forecast
8.3.3.2.1By Drug Type
8.3.3.2.2By Disease Type
8.3.3.2.3By Distribution Channel
8.3.3.2.4By End User
8.3.4South Korea Bleeding Disorders Treatment Market Outlook
8.3.4.1Market Size & Forecast
8.3.4.1.1By Value
8.3.4.2Market Share & Forecast
8.3.4.2.1By Drug Type
8.3.4.2.2By Disease Type
8.3.4.2.3By Distribution Channel
8.3.4.2.4By End User
8.3.5Australia Bleeding Disorders Treatment Market Outlook
8.3.5.1Market Size & Forecast
8.3.5.1.1By Value
8.3.5.2Market Share & Forecast
8.3.5.2.1By Drug Type
8.3.5.2.2By Disease Type
8.3.5.2.3By Distribution Channel
8.3.5.2.4By End User
10.Middle East and Africa Bleeding Disorders Treatment Market Outlook
10.1.Market Size & Forecast
10.1.1.By Value
10.2.Market Share & Forecast
10.2.1.By Drug Type
10.2.2.By Disease Type
10.2.3.By Distribution Channel
10.2.4.By End User
10.2.5.By Country (UAE; Saudi Arabia; South Africa)
10.3.MEA: Country Analysis
10.3.1.South Africa Bleeding Disorders Treatment Market Outlook
10.3.1.1.Market Size & Forecast
10.3.1.1.1.By Value
10.3.1.2.Market Share & Forecast
10.3.1.2.1.By Drug Type
10.3.1.2.2.By Disease Type
10.3.1.2.3.By Distribution Channel
10.3.1.2.4.By End User
10.3.2.Saudi Arabia Bleeding Disorders Treatment Market Outlook
10.3.2.1.Market Size & Forecast
10.3.2.1.1.By Value
10.3.2.2.Market Share & Forecast
10.3.2.2.1.By Drug Type
10.3.2.2.2.By Disease Type
10.3.2.2.3.By Distribution Channel
10.3.2.2.4.By End User
10.3.3.UAE Bleeding Disorders Treatment Market Outlook
10.3.3.1.Market Size & Forecast
10.3.3.1.1.By Value
10.3.3.2.Market Share & Forecast
10.3.3.2.1.By Drug Type
10.3.3.2.2.By Disease Type
10.3.3.2.3.By Distribution Channel
10.3.3.2.4.By End User
11.South America Bleeding Disorders Treatment Market Outlook
11.1.Market Size & Forecast
11.1.1.By Value
11.2.Market Share & Forecast
11.2.1.By Drug Type
11.2.2.By Disease Type
11.2.3.By Distribution Channel
11.2.4.By End User
11.2.5.By Country (Brazil; Argentina; Colombia)
11.3.South America: Country Analysis
11.3.1.Brazil Bleeding Disorders Treatment Market Outlook
11.3.1.1.Market Size & Forecast
11.3.1.1.1.By Value
11.3.1.2.Market Share & Forecast
11.3.1.2.1.By Drug Type
11.3.1.2.2.By Disease Type
11.3.1.2.3.By Distribution Channel
11.3.1.2.4.By End User
11.3.2.Argentina Bleeding Disorders Treatment Market Outlook
11.3.2.1.Market Size & Forecast
11.3.2.1.1.By Value
11.3.2.2.Market Share & Forecast
11.3.2.2.1.By Drug Type
11.3.2.2.2.By Disease Type
11.3.2.2.3.By Distribution Channel
11.3.2.2.4.By End User
11.3.3.Colombia Bleeding Disorders Treatment Market Outlook
11.3.3.1.Market Size & Forecast
11.3.3.1.1.By Value
11.3.3.2.Market Share & Forecast
11.3.3.2.1.By Drug Type
11.3.3.2.2.By Disease Type
11.3.3.2.3.By Distribution Channel
11.3.3.2.4.By End User
12.Market Dynamics
12.1.Drivers
12.2.Challenges
13.Market Trends & Developments
14.Competitive Landscape
14.1.Competition Outlook
14.2.Global Players Profiled (Leading Companies)
14.2.1.Bayer AG
14.2.2.Pfizer Inc.
14.2.3.Grifols S.A.
14.2.4.Octapharma AG
14.2.5.Sun Pharmaceuticals Industries Ltd.
14.2.6.Ferring Pharmaceuticals SA
14.2.7.Amgen Inc.
14.2.8.Sanofi SA
14.2.9.Baxter International Inc.
14.2.10.F. Hoffmann-La Roche Ltd.
14.2.11.Takeda Pharmaceuticals Ltd.
14.2.12.Novo Nordisk A/S
14.2.13.Novartis AG
14.2.14.Eli Lilly and Company Ltd.
14.2.15.Gilead Sciences Inc.
15.Strategic Recommendations
16.About Us & Disclaimer

Report Title: Global Bleeding Disorders Treatment Market By Drug Type (Plasma-derived Coagulation Factor Concentrates, Recombinant Coagulation Factor Concentrates, Desmopressin, Antifibrinolytics, Fibrin Sealants, Others), By Disease Type (Hemophilia A, Hemophilia B, Von Willebrand Disease, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online), By End User (Clinics, Hospitals, Research Institutes, Others) By Region, Competition, Forecast & Opportunities, 2027


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW